NCT01146522View on ClinicalTrials.gov

Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Hyperlipoproteinemia
Interventions
DRUG

LCQ908

DRUG

Placebo

Trial Locations (1)

Unknown

Novartis Investigative Site, Québec

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY